Found 17 matching trials
Pharmacokinetics and Safety of DolutegravIr in Neonate PHASE1 A Phase I/II, open-label, single arm, two-stage trial to evaluate the singl...
Show More Location
Tygerberg Hospital
Learn More & Join Trial
Dolutegravir Study in HIV-1 Participants Completing IMPAACT Studies P1093 and P2019 PHASE3 Dolutegravir is a potent integrase strand transfer inhibitor. Abacavir/dolu...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Bioavailability Study of 10 Milligram (mg) and 5 mg Tablets Versus Conventional Tablets of Dolutegravir PHASE1 The aim of this cross-over study is to compare the relative bioavailability...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Pharmacokinetics, Safety, and Efficacy of Dolutegravir Dispersible Tablets in Young Children Living With HIV PHASE2 The purpose of this study is to evaluate steady-state pharmacokinetics of D...
Show More Location
Division of Infectious disease, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University
Learn More & Join Trial
Safety of and Immune Response to Dolutegravir in HIV-1 Infected Infants, Children, and Adolescents PHASE1 Dolutegravir (DTG) is an HIV drug in the integrase inhibitor drug class. Th...
Show More Location
University of California, UC San Diego CRS- Mother-Child-Adolescent HIV Program (Site ID: 4601)
Learn More & Join Trial
To Assess the Relative Bioavailability (BA) of TRIUMEQ® and Dolutegravir and Lamivudine (DTG/3TC) Pediatric Dispersible Tablet Formulations in Healthy Volunteers PHASE1 This is a 2-part, single-dose, open label, randomized 3-way cross-over stud...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1 PHASE1 The purpose of this study was to evaluate the safety, tolerability, and pha...
Show More Location
USC - Maternal Child Adolescent/Adult Center
Learn More & Join Trial
Relative Bioavailability Study of a Fixed-dose Combination Dolutegravir/Abacavir/Lamivudine Dispersible Tablet PHASE1 This is an open-label, randomized, crossover study in healthy adult subject...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Abacavir, Dolutegravir and Lamivudine Dispersible Tablets (60 mg/5 mg/30 mg) EARLY_PHASE1 The rationale for this study is to evaluate and understand the variability ...
Show More Learn More & Join Trial
DTG/3TC Fixed Dose Formulations for the Maintenance of Virological Suppression in Children With HIV Infection Aged 2 to <15 Years Old PHASE2 This study aims to find out whether treating children and young people livi...
Show More Status
Active Not Recruiting
Location
King Edward VIII Hospital
Learn More & Join Trial